Collapsing the proton motive force to identify synergistic combinations against staphylococcus aureus

Chemistry and Biology

Volumn 20, Issue 9, 2013, Pages 1168-1178

  Farha, Maya A ^a   Verschoor, Chris P ^b   Bowdish, Dawn ^b   Brown, Eric D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHEMICAL STRUCTURE; CYTOTOXICITY; HIGH THROUGHPUT SCREENING; MAMMAL CELL; PRIORITY JOURNAL; PROTON MOTIVE FORCE; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); MAMMALIA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CELL SURVIVAL; DRUG SYNERGISM; ENERGY METABOLISM; HELA CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; PROTON-MOTIVE FORCE; STAPHYLOCOCCUS AUREUS;

EID: 84884512993     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2013.07.006     Document Type: Article

References (47)

1. F.P. Altman Tetrazolium salts and formazans Prog. Histochem. Cytochem. 9 1976 1 56
2. E.P. Bakker, and W.E. Mangerich Interconversion of components of the bacterial proton motive force by electrogenic potassium transport J. Bacteriol. 147 1981 820 826
3. W. Balemans, L. Vranckx, N. Lounis, O. Pop, J. Guillemont, K. Vergauwen, S. Mol, R. Gilissen, M. Motte, and D. Lançois Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria Antimicrob. Agents Chemother. 56 2012 4131 4139
4. I.R. Booth Regulation of cytoplasmic pH in bacteria Microbiol. Rev. 49 1985 359 378
5. I. Chopra Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures Expert Rev. Anti Infect. Ther. 1 2003 45 55
6. A.R. Coates, and Y. Hu Targeting non-multiplying organisms as a way to develop novel antimicrobials Trends Pharmacol. Sci. 29 2008 143 150
7. G. Cottarel, and J. Wierzbowski Combination drugs, an emerging option for antibacterial therapy Trends Biotechnol. 25 2007 547 555
8. R.F. Epand, J.E. Pollard, J.O. Wright, P.B. Savage, and R.M. Epand Depolarization, bacterial membrane composition, and the antimicrobial action of ceragenins Antimicrob. Agents Chemother. 54 2010 3708 3713
9. J.B. Fitzgerald, B. Schoeberl, U.B. Nielsen, and P.K. Sorger Systems biology and combination therapy in the quest for clinical efficacy Nat. Chem. Biol. 2 2006 458 466
10. M.J. Garcerá, M.G. Elferink, A.J. Driessen, and W.N. Konings In vitro pore-forming activity of the lantibiotic nisin. Role of protonmotive force and lipid composition Eur. J. Biochem. 212 1993 417 422
11. B.L. Geller Energy requirements for protein translocation across the Escherichia coli inner membrane Mol. Microbiol. 5 1991 2093 2098
12. D.R. Gentry, I. Wilding, J.M. Johnson, D. Chen, K. Remlinger, C. Richards, S. Neill, M. Zalacain, S.F. Rittenhouse, and M.N. Gwynn A rapid microtiter plate assay for measuring the effect of compounds on Staphylococcus aureus membrane potential J. Microbiol. Methods 83 2010 254 256
13. P.M. Hawkey Pre-clinical experience with daptomycin J. Antimicrob. Chemother. 62 Suppl 3 2008 iii7 iii14
14. Y. Hu, A. Shamaei-Tousi, Y. Liu, and A. Coates A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections PLoS ONE 5 2010 e11818
15. J.G. Hurdle, A.J. O'Neill, I. Chopra, and R.E. Lee Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections Nat. Rev. Microbiol. 9 2011 62 75
16. A. Ikonomidis, A. Tsakris, M. Kanellopoulou, A.N. Maniatis, and S. Pournaras Effect of the proton motive force inhibitor carbonyl cyanide-m-chlorophenylhydrazone (CCCP) on Pseudomonas aeruginosa biofilm development Lett. Appl. Microbiol. 47 2008 298 302
17. G. Kaim, and P. Dimroth ATP synthesis by the F1Fo ATP synthase of Escherichia coli is obligatorily dependent on the electric potential FEBS Lett. 434 1998 57 60
18. C.T. Keith, A.A. Borisy, and B.R. Stockwell Multicomponent therapeutics for networked systems Nat. Rev. Drug Discov. 4 2005 71 78
19. K. Lewis Persister cells, dormancy and infectious disease Nat. Rev. Microbiol. 5 2007 48 56
20. O. McAuliffe, M.P. Ryan, R.P. Ross, C. Hill, P. Breeuwer, and T. Abee Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential Appl. Environ. Microbiol. 64 1998 439 445
21. P. Mitchell Chemiosmotic coupling in oxidative and photosynthetic phosphorylation Biol. Rev. Camb. Philos. Soc. 41 1966 445 502
22. M.M. Nachlas, S.I. Margulies, J.D. Goldberg, and A.M. Seligman The determination of lactic dehydrogenase with a tetrazolium salt Anal. Biochem. 1 1960 317 326
23. B. Nan, J. Chen, J.C. Neu, R.M. Berry, G. Oster, and D.R. Zusman Myxobacteria gliding motility requires cytoskeleton rotation powered by proton motive force Proc. Natl. Acad. Sci. USA 108 2011 2498 2503
24. A.J. O'Neill, and I. Chopra Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques Expert Opin. Investig. Drugs 13 2004 1045 1063
25. Y. Oyamada, H. Ito, M. Fujimoto-Nakamura, A. Tanitame, N. Iwai, K. Nagai, J. Yamagishi, and M. Wachi Anucleate cell blue assay: a useful tool for identifying novel type II topoisomerase inhibitors Antimicrob. Agents Chemother. 50 2006 348 350
26. T.G. Patton, S.J. Yang, and K.W. Bayles The role of proton motive force in expression of the Staphylococcus aureus Cid and lrg operons Mol. Microbiol. 59 2006 1395 1404
27. K. Paul, M. Erhardt, T. Hirano, D.F. Blair, and K.T. Hughes Energy source of flagellar type III secretion Nature 451 2008 489 492
28. I.T. Paulsen, M.H. Brown, and R.A. Skurray Proton-dependent multidrug efflux systems Microbiol. Rev. 60 1996 575 608
29. A. Pelz, K.P. Wieland, K. Putzbach, P. Hentschel, K. Albert, and F. Götz Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus J. Biol. Chem. 280 2005 32493 32498
30. B.M. Peters, M.E. Shirtliff, and M.A. Jabra-Rizk Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog. 6 2010 e1001067
31. M. Prakash Singh Rapid test for distinguishing membrane-active antibacterial agents J. Microbiol. Methods 67 2006 125 130
32. B.P. Ross, A.C. Braddy, R.P. McGeary, J.T. Blanchfield, L. Prokai, and I. Toth Micellar aggregation and membrane partitioning of bile salts, fatty acids, sodium dodecyl sulfate, and sugar-conjugated fatty acids: correlation with hemolytic potency and implications for drug delivery Mol. Pharm. 1 2004 233 245
33. J.B. Russell, and A.J. Houlihan Ionophore resistance of ruminal bacteria and its potential impact on human health FEMS Microbiol. Rev. 27 2003 65 74
34. L.L. Silver Challenges of antibacterial discovery Clin. Microbiol. Rev. 24 2011 71 109
35. J.A. Silverman, N.G. Perlmutter, and H.M. Shapiro Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus Antimicrob. Agents Chemother. 47 2003 2538 2544
36. H.W. Taber, J.P. Mueller, P.F. Miller, and A.S. Arrow Bacterial uptake of aminoglycoside antibiotics Microbiol. Rev. 51 1987 439 457
37. H. Terada Uncouplers of oxidative phosphorylation Environ. Health Perspect. 87 1990 213 218
38. M.C. Trachtenberg, D.J. Packey, and T. Sweeney In vivo functioning of the Na+, K+-activated ATPase Curr. Top. Cell. Regul. 19 1981 159 217
39. A. Ultee, E.P. Kets, and E.J. Smid Mechanisms of action of carvacrol on the food-borne pathogen Bacillus cereus Appl. Environ. Microbiol. 65 1999 4606 4610
40. C. von Eiff, P. McNamara, K. Becker, D. Bates, X.H. Lei, M. Ziman, B.R. Bochner, G. Peters, and R.A. Proctor Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype J. Bacteriol. 188 2006 687 693
41. R.L. White, D.S. Burgess, M. Manduru, and J.A. Bosso Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test Antimicrob. Agents Chemother. 40 1996 1914 1918
42. M. Wilmes, B.P. Cammue, H.G. Sahl, and K. Thevissen Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation Nat. Prod. Rep. 28 2011 1350 1358
43. M. Wu, E. Maier, R. Benz, and R.E. Hancock Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli Biochemistry 38 1999 7235 7242
44. G. Wu, H. Wu, X. Fan, R. Zhao, X. Li, S. Wang, Y. Ma, Z. Shen, and T. Xi Selective toxicity of antimicrobial peptide S-thanatin on bacteria Peptides 31 2010 1669 1673
45. A. Yamaguchi, H. Ohmori, M. Kaneko-Ohdera, T. Nomura, and T. Sawai Delta pH-dependent accumulation of tetracycline in Escherichia coli Antimicrob. Agents Chemother. 35 1991 53 56
46. G.G. Zhanel, D. Calic, F. Schweizer, S. Zelenitsky, H. Adam, P.R. Lagacé-Wiens, E. Rubinstein, A.S. Gin, D.J. Hoban, and J.A. Karlowsky New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin Drugs 70 2010 859 886
47. J.H. Zhang, T.D. Chung, and K.R. Oldenburg A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screen. 4 1999 67 73